Guildford, UK, 27 March 2014: ReNeuron Group plc (the “Company”) (AIM: RENE.L), a leading UK-based stem cell therapy company, is pleased to announce that it has received final UK regulatory and ethical approvals to commence two new clinical trials.

More…

Back